GDNF receptors as a drug target for neural repairBespalov, Maxim M.; Hetenyi, C.; Karelson, Mati; Saarma, MartCell transplantation2007 / 3, p. 313-314 https://www.researchgate.net/publication/295730047_GDNF_receptors_as_a_drug_target_for_neural_repair

Novel computational models for predicting dopamine interactionsKatritzky, Alan R.; Dobchev, Dimitar; Stoyanova-Slavova, Iva B.; Kuanar, Minati; Bespalov, Maxim M.; Karelson, Mati; Saarma, MartExperimental neurology2008 / 1, p. 150-171 https://www.sciencedirect.com/science/article/pii/S0014488608000368

Small molecular weight ARTN mimetic for the treatment of neuropathic painSidorova, Y.A.; Bespalov, Maxim M.; Karelson, Mati; Saarma, MartCell transplantation2012 / p. 792 https://researchportal.helsinki.fi/en/publications/small-molecular-weight-artn-mimetic-for-the-treatment-of-neuropat

The first cysteine-rich domain of the receptor GFR[alpha]1 stabilizes the binding of GDNFVirtanen, Heidi; Yang, Jianmin; Bespalov, Maxim M.; Hiltunen, J.O.; Leppänen, V.M.; Kalkkinen, Nisse; Goldman, A.; Saarma, Mart; Runeberg-Roos, PiaBiochemical journal2005 / 3, p. 817-824 https://pubmed.ncbi.nlm.nih.gov/15610063/

The structure of GFR[alfa]1 domain 3 reveals new insights into GDNF binding and RET activationLeppänen, V.M.; Bespalov, Maxim M.; Runeberg-Roos, Pia; Puurand, Ülo; Merits, Andres; Saarma, Mart; Goldman, A.EMBO journal2004 / 7, p. 1452-1462 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC391078/